Disease-modifying drugs for multiple sclerosis single drug addendum : fingolimod : final original report
PURPOSE: We compared the effectiveness and harms of fingolimod (Gilenya) to other disease-modifying drugs in the treatment of multiple sclerosis. DATA SOURCES: We searched Ovid MEDLINE(r) and the Cochrane Library and the Database of Abstracts of Reviews of Effects through November 2010. For addition...
| Main Author: | |
|---|---|
| Corporate Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Portland, Or.
Oregon Health & Science University
c2011, 2011
|
| Series: | Drug class review
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references